Issues in transfusing preterm infants in the NICU

Journal of Perinatal and Neonatal Nursing

Volumn 18, Issue 2, 2004, Pages 170-182

  Bain, Annamarie ^a   Blackburn, Susan ^b  

^a Legacy Emanuel Children's Hospital   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Anemia of prematurity; Blood transfusion; Preterm infant

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CARDIOVASCULAR SYMPTOM; CELL SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DECISION MAKING; DONOR; DRUG DOSE REDUCTION; DRUG EFFECT; ERYTHROCYTE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; IATROGENIC DISEASE; INFANT; INFECTION; META ANALYSIS; MOTHER; NEWBORN; NEWBORN INTENSIVE CARE; OXYGEN AFFINITY; PREMATURITY; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYMPTOM; BLOOD DONOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; MALE; METHODOLOGY; NEWBORN ANEMIA; NEWBORN NURSING; TREATMENT OUTCOME;

ANEMIA, NEONATAL; BLOOD DONORS; BLOOD TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; NEONATAL NURSING; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 14044260739     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200404000-00011     Document Type: Review

References (50)

1. Strauss RG. Practical issues in neonatal transfusion practice. Am J Clin Pathol. 1997;107(4, suppl 1):S57-S63.
2. Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediatr. 2002;141:3-4.
3. Kabra NS. Blood transfusion in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F78.
4. Simpson J, Kinsey S. Pediatric transfusion. Vox Sang. 2001;81:1-5.
5. Blackburn ST. Maternal, Fetal and Neonatal Physiology: A Clinical Perspective. 2nd ed. Philadelphia: Saunders; 2003:246.
6. Doyle JJ, Schmidt B, Blanchette V, Zipursky A. Hematology. In: Avery GB, Fletcher MA, Macdonald MG, eds. Neonatology-Pathophysiology and Management of the Newborn. 5th ed. Philadelphia: Lippincott; 1999:1045-1091.
7. Ohls RK. Evaluation and treatment of anemia in the neonate. In: Christensen R, ed. Hematologic Problems of the Neonate. Philadelphia: Saunders; 2000:137-169.
8. Carbonell-Estrany X, Figueras-Aloy J. Anaemia of prematurity: treatment with erythropoietin. Early Hum Dev. 2001;65(suppl):S63-S67.
9. Ng PC, Lam CWK, Lee CH, et al. Hepatic iron storage in very low birthweight infants after multiple blood transfusions. Arch Dis Child Fetal Neonatal Ed. 2001;84:F101-F105.
10. Roseff SD, Luban NL, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion. 2002;42:1398-1413.
11. Lachance C, Chessex P, Fouron JC, et al. Myocardial, erythropoietic and metabolic adaptations to anemia of prematurity. J Pediatr. 1994;125:278-282.
12. Ohls RK. The use of erythropoietin in neonates. Clin Perinatol. 2000;27:681-696.
13. Ohls RK. Ehrenkranz RA, Wright LL, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001;108:934-942.
14. Shannon KM, Keith JF III, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995;95:1-8.
15. Cohen A, Manno C. Transfusion practices in infants receiving assisted ventilation. Clin Perinatol. 1998;25:97-111.
16. Hume H. Red blood cell transfusions for preterm infants. The role of evidence-based medicine. Semin Perinatol. 1997;21:8-19.
17. British Committee for Standards in Haematology (BCSH), Transfusion Task Force. Transfusion guidelines for neonates and older children. 2003. Available at: http://www.bcshguidelines.com/guidelines.asp. Accessed February 12, 2004.
18. Bednarek FJ, Weisberger S, Richardson DK, et al. Variations in blood transfusions among newborn intensive care units. SNAP II Study Group. J Pediatr. 1998;133:601-607.
19. Andersen C. Critical haemoglobin thresholds in premature infants. Arch Dis Child Fetal Neonatal Ed. 2001;84:F146-F148.
20. Ramasethu J, Luban NC. Red blood cell transfusions in the newborn. Semin Neonatol. 1999;4:5-16.
21. Westcamp E, Soditt V, Adrain S, et al. Blood transfusion in anemic infants with apnea of prematurity. Biol Neonate. 2002;82:228-232.
22. Juul SE. Erythropoiesis in the neonate. Curr Probl Pediatr. 1999;29:129.
23. Maier RF, Sonntog J, Walka MM, Liu G, Metze BC, Obladen M. Changing practices of red blood cell transfusion in infants with birth weights less than 1000 g. J Pediatr. 2000;136:220.
24. Widness JA, Seward VJ, Kromer IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr. 1996;129:680-687.
25. Kabra NS, Kirpalani H. Blood transfusions in the premature nursery. Indian Pediatr. 2002;39:619-624.
26. Wardle SP, Garr R, Yoxall CW, Weinfling AM. A pilot randomized controlled trial of peripheral fractional oxygen extraction to guide blood transfusion in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002;86:F22-F27.
27. Meyer J, Sive A, Jacobs P. Empiric red cell transfusion in asymptomatic preterm infants. Acta Pediatr. 1993;82:30-34.
28. Alkalay AI, Galvis S, Ferry DA, et al. Packed red blood cell transfusions do not modify cardiac function of premature infants with "very low hematocrits." J Clin Invest. 1999;47:57.
29. Stute H, Greiner B, Linderkamp O. Effect of blood transfusion on cardiorespiratory abnormalities in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1995;72:F194-F196.
30. Poets CF, Paul U, Bohnhorst B. Effect of blood transfusion on apnea, bradycardia and hypoxemia in preterm infants. Eur J Pediatr. 1997;156:311-316.
31. Dani C, Pezzati M, Martelli E, et al. Effect of blood transfusions on cerebral hemodynamics in preterm infants. Acta Paediatr. 2002;91:938-941.
32. Strauss RG. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin. Transfus Med Rev. 2001;15:213-223.
33. Kirpalani H, Leaman E, McLean M, et al. A directed donation program reduces allogenic blood exposure in neonatal intensive care. Pediatr Res. 1998;43:239A.
34. Strauss RG. Data-driven blood banking practices for neonatal RBC transfusions. Transfusion. 2000;40:1528-1540.
35. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed. 2001;84(2):F96-F100.
36. Fergusson D, Hebert PC, Lee SK, et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA. 2003;289:1950-1956.
37. Lasker MR, Eddleman K, Toor AH. Neonatal hepatitis and excessive hepatic iron deposition following intrauterine blood transfusion. Am J Perinatol. 1995;12:14-17.
38. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion, retinopathy of prematurity and iron load in preterm infants. Eur J Pediatr. 1997;156:465-470.
39. Luchtman L, Schwartz AL, Wilson DB. Blood component therapy for the neonate. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine, Diseases of the Fetus and Infant. 6th ed. St Louis: Mosby; 2002:1201-1252.
40. Kenner C, Lott, JW. Comprehensive Neonatal Nursing: A physiologic Perspective. 3rd ed. Philadelphia: Saunders; 2003.
41. Donato H, Vain N, Rendo P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants. Pediatrics. 2000;105:1066-1072.
42. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F41-F45.
43. Maier RF, Obladen M, Muller-Hansen J, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr. 2002;141:8-15.
44. Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion. 2001;41:406-415.
45. Avent M, Corg BJ, Galpin J, et al. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anemia of prematurity in a developing country. J Trop Pediatr. 2002;48:227-233.
46. Newton NR, Leonard CH, Oiecuch RE, Phibbs RH. Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy. J Perinatol. 1999;19:403-406.
47. Ehrenkranz R, Ohls RK, Das A, Vohr BR. Neurodevelopmental outcome and growth at 18-22 months in ELBW infants treated with erythropoietin and iron. Pediatr Res. 2002;51:291A.
48. Lin JC, Strauss RG, Kulhavy JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery, Pediatrics. 2000;106:e19.
49. Weiss M, Fischer J, Boeckmann M, et al. Evaluation of a simple method for minimizing iatrogenic blood loss from discard volumes in critically ill newborns and children. Intensive Care Med. 2001;27:1064-1072.
50. Windess JA, Madan A, Stevenson DK. Reduction in RBD transfusions among newborn infants: results of a randomized trial using an IN-line point-of-care blood gas and electrolyte monitor. Pediatr Res. 2002;51:376A.